BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Quercetin
,
rs4950928
,
PTEN
,
Angiogenesis
,
Leukemia
,
Leukocyte
,
Amniocentesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
pol iii
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Embryonic kidney 293 cells with ZSCAN5A siRNA knockdown
Embryonic kidney 293T cells with AGO2 shRNA knockdown
Transcriptional control by the FATC domain of S cerevisiae Tra1
Embryonic kidney HEK293 cells overexpressing mutant or wildtype DIS3L2
Prefrontal cortices of 20mo old POLB/- mice in an Alzheimer's disease model
Explore Curated Studies Results
Literature
Most Relevant Literature
The SAGA Deubiquitinilation (DUB) Module Participates in Pol III-Dependent Transcription].
Architecture of the yeast Pol III pre-termination complex and pausing mechanism on poly(dT) terminat…
Tau Mediated Coupling Interactions between Pol III Core DNA Synthesis and DnaB Helicase Unwinding.
Clinical consequences of the presence of anti-RNA Pol III antibodies in systemic sclerosis.
During Translesion Synthesis, Escherichia coli DinB89 (T120P) Alters Interactions of DinB (Pol IV) w…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adu…
A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047,…
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
A Phase III Study of Safety and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and A…
GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ